Objective: to observe the influence of aging on urinary secretion of 3-hydroxyproline (3-Hyp) in normal subjects and in cancer patients and study the effects of aging on the accuracy of urinary 3-Hyp as a general-purpose cancer screening test. Design: We reanalyzed, from the aspect of gerontology, the amounts of 3-Hyp in the urine samples of the 211 healthy persons and 94 patients with cancer reported earlier. The two groups were divided in 3 age subgroups: adult, 30 to 44 years, middle-aged, 45 to 64 years, and aged, 65 years and older. The cancer stage was separated into 3 categories: stage 1, the early stage without any invasion, stage 2, locally invasive with no distant metastasis, and stage 3, advanced cancer. The correlation of age and urinary 3-Hyp was analyzed in normal subjects and cancer patients.
Measurement of the urinary 3-hydroxyproline (3-Hyp) level has been reported for use in a general screening test for all cancers sites8). It is an amino acid found primarily in type IV collagen, the main component of extracellular membranes9), and is eliminated in the urine10). The elevation of the excretion of 3-Hyp is related to increased catabolism of collagen8,9). Cancer leads to the destruction of extracellular membranes, inducing an increase in urinary elimination of 3-Hyp8). As the metabolism of collagen decreases with aging11), it is expected that the normal urinary excretion of endogenous 3-Hyp should also decrease. With a lower metabolic rate of collagen, the destruction of collagen by cancer invasion in the elderly should provoke a bigger and faster alteration than in other age groups. In a reevaluation of our earlier report, we examined the influence of aging on the urinary excretion of endogenous 3-Hyp in normal subjects (control group) and in cancer patients, and its influence on the effectiveness of urinary 3-Hyp in screening for cancer in general.
Material and Methods

Control group
As the control group we used 211 persons with ages ranging from 31 to 83 years; 140 were men and 71
women. The control group was selected from among 997 persons who submitted to medical examination for a health check-up, at a special center, the Cases and controls were classified by age into 3 groups: adult (from 31 to 44 years), middle-aged (45 to 64 years) and aged (65 years and over), as shown in Table 2 . We also compared the efficacy of urinary 3-Hyp testing for the stomach cancer with that for the other cancers.
Urine sampling and analysis
To avoid the effect of dietary 3-Hyp we collected the first fasting spot urine of all subjects. The 3-Hyp was measured using an Hitachi amino acid auto analyzer, corrected for the urinary creatinine level and expressed in mg/g of creatinine, as described previously8). The reproducibility of the determination of 3-Hyp in urine samples has been reported8).
The variation was within 3% in day-to-day examinations.
Statistical methodology
The mean value, standard deviation (s. The scatter diagram with the regression line ( Figure   1 ) of age and urinary 3-Hyp shows a significant decrease in the excretion of this amino acid with the increase of age in the control group. The correlation coefficient was -0.250 (p<0.001). groups. These differences were not significant ( The paired sensitivity/specificity ratios for dif- Table 6 . The cutoff point of 0.800mg/g creatinine had a specificity of 97%, a sensitivity of 29% and a positive predictive value of 57%, for the adult group, while the middleaged group had a specificity of 96%, sensitivity of 46%, and predictive value of 83%. Using the same cutoff of 0.800mg/g creatinine, the aged group presented the best specificity (100%), but a lower sensitivity (38%). However, using a more moderated threshold, 0.600mg/g creatinine, the aged group showed a sensitivity of 62% with a specificity of 100%. Using the 0.600 threshold for the adult group, the specificity decreased to 87% and the predictive value to 27%, while for the middle-aged the specificity was 91%, sensitivity 61% and predictive value 77%.
ROC curves for all stages of cancer ( Figure 3) showed the aged-group curve figures in the upper ROC curves for stage 1 cancer (Figure 4 ) showed a clear difference between the adult group, and the others. The aged and middle-aged groups showed a small difference. The areas under ROC curves for Table 6 Specificity, sensitivity and positive predictive values of diverse cutoff points of urinary 3-Hyp in mg/g creatinine, for cancer screening, in the different age groups.
Each value represents the percentage. In this report we observed that in normal subjects the urinary excretion of 3-Hyp decreased with aging.
However, in patients with cancer the linear regression of urinary 3-Hyp by age was almost horizontal. The sensitivity of other cancer markers has been reported to be high in some organ cancers and low in others8). For instance, CA 19-9 is elevated in 69% of pancreatic cancer patients, while for the carcinoembryonic antigen this proportion is 56%18). However, the sensitivity of CA 19-9 for colon cancer, in the high risk population19), is 23% and carcinoembryonic antigen has been reported to have a sensitivity of 32% for lung cancer20). Until now, no cancer marker has Fig. 6 Regression lines of urinary 3-Hyp and age for both cancer patients and healthy subjects.
been shown to be applicable for an all purpose cancer screening test. Urinary 3-Hyp is reported to have a good sensitivity for all kinds of studied cancers8).
This quality makes urinary 3-Hyp useful for screening cancer in the general population, and it could be utilized as part of an annual health-check program.
The frequency of this health check should be determined by the increase of the sensitivity up to a reasonable level.
The authors stress the value of urinary 3-Hyp in cancer screening, mainly for the elderly, and it is important to verify the effectiveness of this test in a large population-based study.
